Skip to content
LexBuild

Notice of Correction

---
identifier: "/us/fr/02-10983"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Notice of Correction"
title_number: 0
title_name: "Federal Register"
section_number: "02-10983"
section_name: "Notice of Correction"
positive_law: false
currency: "2002-05-03"
last_updated: "2002-05-03"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-10983"
document_type: "notice"
publication_date: "2002-05-03"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "67 FR 22436"
fr_volume: 67
fr_action: "Notice; Correction."
---

#  Notice of Correction

**ACTION:**

Notice; Correction.

In the *Federal Register* of April 17, 2002, Volume 67, Number 74, Page 18911 the following should read as follows:

**Correction**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES**

**Centers for Disease Control and Prevention**

**Centers for Disease Control and Prevention: Meeting**

The Centers for Disease Control and Prevention (CDC) announces the following committee meeting:

*Name:* Advisory Committee on Immunization Practices, Smallpox Working Group.

*Times and Dates:*

9 a.m.-12 p.m., May 8, 2002 (Closed).

1 p.m.-9 p.m., May 8, 2002.

8:30 a.m.-11:30 a.m., May 9, 2002.

*Place:* Atlanta Marriott Century Center, 2000 Century Boulevard, NE, Atlanta, Georgia 30345-3377.

*Status:* Closed 9 a.m.-12 p.m., May 8, 2002. Remainder of meeting open to the public, limited only by the space available.

*Purpose:* The working group will convene in closed session from 9 a.m.-12 a.m., May 8, 2002. During the open session the working group will gather information and formulate options to be presented to the Advisory Committee on Immunization Practices for its deliberation in making recommendations for the use of vaccinia (smallpox) vaccine.

*Matters To Be Discussed:* The panel will gather information regarding the use of vaccinia (smallpox) vaccine.

*Contact Person for More Information:* Gloria A. Kovach, Program Analyst, Epidemiology and Surveillance Division, National Immunization Program, CDC,1600 Clifton Road, NE, m/s E61, Atlanta, Georgia 30333. Telephone 404/639-8096.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: April 29, 2002.

John Burckhardt,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.